David A Zisman
Overview
Explore the profile of David A Zisman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Rahaghi F, Kolaitis N, Adegunsoye A, de Andrade J, Flaherty K, Lancaster L, et al.
Chest
. 2022 Feb;
162(1):145-155.
PMID: 35176276
Background: Pulmonary hypertension (PH) is a common complication of interstitial lung disease (ILD) and is associated with worse outcomes and increased mortality. Evaluation of PH is recommended in lung transplant...
3.
Zisman D, Schwarz M, Anstrom K, Collard H, Flaherty K, Hunninghake G
N Engl J Med
. 2010 May;
363(7):620-8.
PMID: 20484178
Background: Sildenafil, a phosphodiesterase-5 inhibitor, may preferentially improve blood flow to well-ventilated regions of the lung in patients with advanced idiopathic pulmonary fibrosis, which could result in improvements in gas...
4.
Lynch 3rd J, Fishbein M, Saggar R, Zisman D, Belperio J
Expert Rev Respir Med
. 2010 May;
1(3):377-89.
PMID: 20477177
Idiopathic pulmonary fibrosis (IPF; also known as cryptogenic fibrosing alveolitis) is a distinctive type of chronic fibrosing interstitial pneumonia of unknown cause associated with the histological pattern usual interstitial pneumonia...
5.
Saggar R, Shapiro S, Ross D, Fishbein M, Zisman D, Lynch 3rd J, et al.
J Heart Lung Transplant
. 2009 Sep;
28(9):964-7.
PMID: 19716051
The available therapies and prognosis of idiopathic pulmonary fibrosis remain relatively poor, and concurrent pulmonary hypertension further increases the risk of death and complications after lung transplantation. Limited data exist...
6.
Saggar R, Saggar R, Aboulhosn J, Belperio J, Zisman D, Lynch 3rd J
Semin Respir Crit Care Med
. 2009 Jul;
30(4):399-410.
PMID: 19634079
Pulmonary hypertension (PH) can occur as either a primary or a secondary process, and in general, its presence increases overall morbidity and mortality. Importantly, the majority of prior studies have...
7.
Zisman D, Kawut S
Am J Respir Crit Care Med
. 2008 Dec;
178(12):1192-3.
PMID: 19050202
No abstract available.
8.
Zisman D, Kawut S, Lederer D, Belperio J, Lynch 3rd J, Schwarz M, et al.
Chest
. 2008 Nov;
135(4):929-935.
PMID: 19017875
Background: Hypoalbuminemia is a reliable predictor of mortality in patients with various illnesses as well as a predictor of disability and mortality in healthy older adults. The association between hypoalbuminemia...
9.
Nathan S, Shlobin O, Barnett S, Saggar R, Belperio J, Ross D, et al.
Respir Med
. 2008 Jul;
102(9):1305-10.
PMID: 18619825
Rationale: Pulmonary hypertension (PH) commonly complicates the course of patients with idiopathic pulmonary fibrosis (IPF). It has a significant impact on outcomes and is, therefore, important to detect. Objectives: We...
10.
Zisman D, Karlamangla A, Kawut S, Shlobin O, Saggar R, Ross D, et al.
Chest
. 2008 Jan;
133(3):640-5.
PMID: 18198245
Background: We have developed a method to screen for pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) patients, based on a formula to predict mean pulmonary artery pressure (MPAP) from...